Cipla is committed to transparency in financial relationships with Healthcare Professionals (HCPs) and Healthcare Organisations (HCOs).
Cipla is committed to compliance by disclosing our financial relationships as required by the Association of the British Pharmaceutical Industry (ABPI) Code of Practice.
Working with Healthcare Professionals (HCPs) and Healthcare Organisations (HCOs)
Cipla works with HCPs and HCOs to improve the development and delivery of our medicines for patients.
In line with current ABPI requirements, Cipla submits information regarding transfers of value made to HCPs and HCOs to the ABPI central disclosure platform. For further information, please visit
Patient Organisations and Members of the Public
In line with the ABPI Code, Cipla is providing details of the Patient Organisations and Members of the Public it partners with, including monetary and non-monetary support.
In 2023, 2024 and 2025 Cipla did not provide monetary or non-monetary support to UK Patient Organisations or Members of the Public.
2022 support provided to UK Patient Organisations
| Patient organisation | Description of activity or project support | Net value of support (£) |
|---|---|---|
| Asthma and Lung UK | Unrestricted donation | £1000 |
Click here to learn more about the Methodological Note for Cipla's Report on Transfers of Value to Patient Organisations and Members of the Public.
View PDF